E. Ohman J:or Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-5,000
| Closed | -$487K | – | 441 |
|
|
2022
Q2 | $487K | Buy |
5,000
+3,300
| +194% | +$322K | 0.02% | 355 |
|
|
2022
Q1 | $159K | Buy |
+1,700
| New | +$159K | 0.01% | 421 |
|
|
2021
Q4 | – | Sell |
-3,900
| Closed | -$374K | – | 476 |
|
|
2021
Q3 | $374K | Hold |
3,900
| – | – | 0.01% | 427 |
|
|
2021
Q2 | $380K | Buy |
3,900
+2,200
| +129% | +$214K | 0.01% | 437 |
|
|
2021
Q1 | $165K | Buy |
+1,700
| New | +$165K | 0.01% | 438 |
|